Ahmed Bahi on Qatar’s Self-Infusion Program for Hemophilia Patients
Ahmed Bahi, Critical Care Pharmacist Specialist in Trauma Services at Hamad Medical Corporation, shared on LinkedIn:
”Exciting News from Qatar!
I’m thrilled to share the successful establishment of our self-infusion program for hemophilia patients, a collaborative effort between Qatar Foundation Health Group (QFHG) and the Hematology/Oncology team at Hamad Medical Corporation’s National Center for Cancer Care and Research (NCCCR).
This initiative included comprehensive didactic lectures and hands-on live stations, culminating in a knowledge assessment survey to ensure our patients feel empowered and informed.
A heartfelt thank you to everyone involved, especially:
– Dr. Osama Elhomsi
– Dr. Honar Cherif
– Dr. Liam Ferrnough
– Dr.Sheab Fared
– Dr.Amna Jameel
– Dr.Deena Mudawi
Your dedication and expertise made this program a reality, significantly improving the quality of life for hemophilia patients in our community.
Together, we are making strides toward better healthcare and patient empowerment!”

Stay updated with Hemostasis Today.
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026
-
Jul 13, 2026, 16:06Dino Mehic: Honored to Receive the ISTH Early Career Top Reviewer Awards
-
Jul 13, 2026, 16:01Advancing DIC Diagnosis in Cirrhosis Through Disease-Specific Risk Stratification – JTH
-
Jul 13, 2026, 15:52Joshua Muia: Presenting Our Research on ADAMTS13/VWF Dysregulation in Sepsis at ISTH 2026
-
Jul 13, 2026, 15:42Marc Carrier: Important New Data From the API-CAT Trial on Recurrent VTE During Extended Apixaban Therapy
-
Jul 13, 2026, 15:23Akshat Jain: 5 Key Clinical Takeaways from ISTH 2026
-
Jul 13, 2026, 15:15Alfonso J. Tafur: Insights on Periprocedural DOAC Management in Atrial Fibrillation at ISTH 2026